Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-09T03:54:04.219Z Has data issue: false hasContentIssue false

OLANZAPINE

Published online by Cambridge University Press:  03 May 2024

Stephen M. Stahl
Edited in association with
Jeffrey R. Strawn
Stephen M. Stahl
Affiliation:
University of California, San Diego
Jeffrey R. Strawn
Affiliation:
University of Cincinnati, Ohio
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Prescriber's Guide – Children and Adolescents
Stahl's Essential Psychopharmacology
 , pp. 387 - 396
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Suggested Reading

DelBello, MP, Bruns, KM, Bloom, T et al. A double-blind placebo-controlled pilot study of topiramate in manic adolescents treated with olanzapine. J Child Adolesc Psychopharmacol 2023;33(4):126–33.CrossRefGoogle ScholarPubMed
Detke, HC, DelBello, MP, Landry, J, Usher, RW. Olanzapine/fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2015;54(3):217–24.CrossRefGoogle ScholarPubMed
Ellul, P, Delorme, R, Cortese, S. Metformin for weight gain associated with second-generation antipsychotics in children and adolescents: a systematic review and meta-analysis. CNS Drugs 2018;32(12):1103–12.CrossRefGoogle ScholarPubMed
Han, R, Bian, Q, Chen, H. Effectiveness of olanzapine in the treatment of anorexia nervosa: A systematic review and meta-analysis. Brain Behav 2022;12(2):e2498.CrossRefGoogle ScholarPubMed
Koch, MT, Carlson, HE, Kazimi, MM, Correll, CU. Antipsychotic-related prolactin levels and sexual dysfunction in mentally ill youth: a 3-month cohort-study. J Am Acad Child Adolesc Psychiatry 2023 ;62(9):1021–50.CrossRefGoogle ScholarPubMed
Kryzhanovskaya, L, Schulz, SC, McDougle, C et al. Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2009;48(1):60–70.CrossRefGoogle ScholarPubMed
Lytle, S, McVoy, M, Sajatovic, M. Long-acting injectable antipsychotics in children and adolescents. J Child Adolesc Psychopharmacol 2017;27(1):2–9.CrossRefGoogle ScholarPubMed
Miklowitz, DJ, Schneck, CD, Walshaw, PD et al. Effects of family-focused therapy vs enhanced usual care for symptomatic youths at high risk for bipolar disorder: a randomized clinical trial. JAMA Psychiatry 2020;77(5):455–63.CrossRefGoogle ScholarPubMed
Pillay, J, Boylan, K, Carrey, N et al. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update [Internet]. Rockville, MD: Agency for Healthcare Research and Quality (US); 2017 Mar. Report No.: 17-EHC001-EF. AHRQ Comparative Effectiveness Reviews.Google Scholar
Stentebjerg-Olesen, M, Ganocy, SJ, Findling, RL et al. Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial. Eur Child Adolesc Psychiatry 2015;24(12):1485–96.CrossRefGoogle ScholarPubMed
Strawn, JR, Delbello, MP. Olanzapine for the treatment of bipolar disorder in children and adolescents. Expert Opin Pharmacother 2008;9(3):467–74.CrossRefGoogle ScholarPubMed
Xiao, L, Ganocy, SJ, Findling, RL, et al. Baseline characteristics and early response at week 1 predict treatment outcome in adolescents with bipolar manic or mixed episode treated with olanzapine: results from a 3-week, randomized, placebo-controlled trial. J Clin Psychiatry 2017;78(9):e1158-66.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • OLANZAPINE
  • Stephen M. Stahl, University of California, San Diego
  • Edited in association with Jeffrey R. Strawn, University of Cincinnati, Ohio
  • Book: Prescriber's Guide – Children and Adolescents
  • Online publication: 03 May 2024
  • Chapter DOI: https://doi.org/10.1017/9781009267526.042
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • OLANZAPINE
  • Stephen M. Stahl, University of California, San Diego
  • Edited in association with Jeffrey R. Strawn, University of Cincinnati, Ohio
  • Book: Prescriber's Guide – Children and Adolescents
  • Online publication: 03 May 2024
  • Chapter DOI: https://doi.org/10.1017/9781009267526.042
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • OLANZAPINE
  • Stephen M. Stahl, University of California, San Diego
  • Edited in association with Jeffrey R. Strawn, University of Cincinnati, Ohio
  • Book: Prescriber's Guide – Children and Adolescents
  • Online publication: 03 May 2024
  • Chapter DOI: https://doi.org/10.1017/9781009267526.042
Available formats
×